Integrated Filing — IndAS



General information about company
Scrip Code 544122
NSE Symbol ENTERO
MSEI Symbol LISTED
ISIN INE010601016
Name of company Entero Healthcare Solutions Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2025
Date of end of financial year 31-Mar-2026
Date of board meeting when results were approved 08-Aug-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter First quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended
Segment Reporting Single segment
Description of single segment Distribution of Pharmaceuticals, surgicals and other healthcare and allied products
Start date and time of board meeting 08-Aug-2025   14:30:00
End date and time of board meeting 08-Aug-2025   17:30:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2025
B Date of end of reporting period 30-Jun-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 14038190000
Other income 58250000
Total income 14096440000
2 Expenses
(a) Cost of materials consumed 0
(b) Purchases of stock-in-trade 12990160000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -347680000
(d) Employee benefit expense 575570000
(e) Finance costs 106640000
(f) Depreciation, depletion and amortisation expense 88690000
(f) Other Expenses
1 Distributon Cost 103460000 103460000
2 Legal and Professional Charges 34530000 34530000
3 Travelling Expenses 29600000 29600000
4 Business Promotion expenses 36880000 36880000
5 Power and fuel 21450000 21450000
6 Repair and Maintenance 14270000 14270000
7 Printing and Stationery 11240000 11240000
8 IT Expenses 6340000 6340000
9 Insurance 6700000 6700000
10 Other 54960000 54960000
Total other expenses 319430000
Total expenses 13732810000
3 Total profit before exceptional items and tax 363630000
4 Exceptional items 0
5 Total profit before tax 363630000
6 Tax expense
7 Current tax 81090000
8 Deferred tax -19780000
9 Total tax expenses 61310000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0
11 Net Profit Loss for the period from continuing operations 302320000
12 Profit (loss) from discontinued operations before tax 0
13 Tax expense of discontinued operations 0
14 Net profit (loss) from discontinued operation after tax 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0
16 Total profit (loss) for period 302320000
17 Other comprehensive income net of taxes 1220000
18 Total Comprehensive Income for the period 303540000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 277990000
Total profit or loss, attributable to non-controlling interests 24330000
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 278910000
Total comprehensive income for the period attributable to owners of parent non-controlling interests 24620000
21 Details of equity share capital
Paid-up equity share capital 435090000
Face value of equity share capital 10
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 6.39
Diluted earnings (loss) per share from continuing operations 6.38
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0
Diluted earnings (loss) per share from discontinued operations 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 6.39
Diluted earnings (loss) per share from continuing and discontinued operations 6.38
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2025
Date of end of reporting period 30-Jun-2025
Whether accounts are audited or unaudited Unaudited
Nature of report standalone or consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2025
B Date of end of reporting period 30-Jun-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement gain/(loss) on defined benefit plan 1640000 1640000
Total Amount of items that will not be reclassified to profit and loss 1640000
2 Income tax relating to items that will not be reclassified to profit or loss 420000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income 1220000